RES, by down-regulating the PI3K/AKT/NF-κB pathway, inhibits the invasion of glioblastoma-initiating cells in glioblastoma [145], and in human glioma cells U373M, it regulates NF-κB-dependent TNF-α expression by reducing cell invasion [138]. Here, NFKB1 is linked to central nervous system cancer.